National heart muscle disease registry study
Part of Heart & circulation clinical trials.
This study collects information over time from people with different types of cardiomyopathy (a disease of the heart muscle). By tracking your health, doctors hope to learn more about these conditions and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have one of these heart muscle conditions: hypertrophic, dilated, arrhythmogenic, or restrictive cardiomyopathy, left ventricular non-compaction, cardiac amyloidosis, Fabry disease, Pompe disease, Danon disease, or PRKAG2 cardiac syndrome.
- You must have been diagnosed with this condition as a primary reason for a hospital stay.
- You must agree to sign a consent form saying you want to join the study.
- You must be willing to come back for check-ups or answer follow-up calls as part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at people with cardiomyopathy to understand which patients are most in need of a heart transplant. By joining, you will help doctors learn more about critical cases and improve care for heart muscle disease.
This study collects health records, heart ultrasound (echo), MRI images, and optional DNA testing for people with hypertrophic cardiomyopathy (HCM). It aims to build a large database to better understand HCM and support future research and care.
This trial aims to better understand and treat cardiomyopathy by studying patients' hearts with advanced tests. It seeks to find new ways to prevent or manage the condition early.
This trial is a registry, meaning it collects health information to help doctors study heart muscle diseases and plan future cardiovascular studies. You may be able to join if you have a non-ischemic cardiomyopathy such as dilated cardiomyopathy, certain forms of thick heart muscle, non-compaction, or arrhythmogenic right-sided disease.
This study enrolls people with certain types of heart muscle diseases to learn how blocked heart arteries and tiny blood vessels affect symptoms and outcomes. It may help researchers better understand these conditions and improve future care.
This registry collects information about people with hypertrophic cardiomyopathy (HCM) to better understand the condition and improve care. It is for patients who have a confirmed HCM diagnosis not caused by other issues.
Hear when a new Cardiomyopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.